Stay updated with the Cipla Stock Liveblog, your one-stop destination for real-time information and analysis of a leading ...

Stay updated with the Cipla Stock Liveblog, your one-stop destination for real-time information and analysis of a leading ...

The drug major said that the US Food and Drug Administration (USFDA) has issued eight observations to the company's manufacturing facility located at Virgonagar, Bengaluru.

India's benchmark Nifty 50 index is set to open marginally higher on Thursday after sinking into correction territory in the ...

Following an inspection of its Bengaluru facility, Cipla has received 8 observations in Form 483 from the US Food and Drug ...

NSE's Nifty50 tumbled 324.40 points, or 1.36 per cent, to close at 23,559.05 for the day. Some buzzing pharma stocks ...

Cipla's shares have risen 28.26% over the past year, though they have experienced some volatility in recent months, including a 7% decline in the last month. The surge follows the US Food and Drug ...

Cipla share price today: The pharma major reported a 15.2% year-on-year rise in its consolidated net profit Q2 FY25 to Rs 1,303.53 crore. (Image: Reuters) Cipla shares soared 10% to an intraday ...

Cipla Ltd. shares jumped over 10 per cent in early trading on Thursday after the USFDA classified its Goa facility as a “Voluntary Action Indicated" (VAI) status. The Goa facility was earlier ...

Stock Market Today: Cipla share price gained 10% in the morning trade on Thursday, October 31 after the company announced that its Goa facility has been classified as Voluntary Action Indicated (VAI).

Cipla Ltd. shares jumped over 10% in early trading on Thursday after the USFDA classified its Goa facility as a "Voluntary Action Indicated" (VAI) status. The Goa facility was earlier re-inspected by ...

Cipla Ltd. shares jumped over 10% in early trade on Thursday after the USFDA classified its Goa facility as “Voluntary Action Indicated” (VAI). The authority previously re-inspected the Goa ...